• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

First Patient-to-Patient Intrahospital Transmission of Clade I Candida auris in France Revealed after a Two-Month Incubation Period - ASM Journals

Mary Wilson

Well-known member
American Society for Microbiology

12 September 2022

DOI: https://doi.org/10.1128/spectrum.01833-22

Alexandre Alanio[SUP]a,b,c[/SUP], Hannah Marie Snell[SUP]d[/SUP], CamilleCordier[SUP]b[/SUP], Marie Desnos-Olivier[SUP]a[/SUP], Sarah Dellière[SUP]a,b,c[/SUP], Nesrine Aissaoui[SUP]b[/SUP], Aude Sturny-Leclère[SUP]a[/SUP], ElodieDa Silva[SUP]b[/SUP], Cyril Eblé[SUP]d[/SUP], Martine Rouveau[SUP]d[/SUP], MichelineThégat[SUP]d[/SUP], Widad Zebiche[SUP]d[/SUP], Matthieu Lafaurie[SUP]e[/SUP], BlandineDenis[SUP]e[/SUP], Sophie Touratier[SUP]f[/SUP], Mourad Benyamina[SUP]g,h[/SUP], Emmanuel Dudoignon[SUP]g,h[/SUP], Samia Hamane[SUP]b[/SUP], Christina A.Cuomo[SUP]d[/SUP], François Dépret[SUP]c,g,h,i,j,k[/SUP]

ABSTRACT

Candida auris is a recently described emerging pathogen in hospital settings. Five genetic clades have been delineated, with each clade being isolated from specific geographic regions. We here describe the first transmission between 2 patients (P0 and P1) of a clade I C. auris strain imported into our burn intensive care unit from the Middle East. The strains have been investigated with whole-genome sequencing, which validated the high similarity of the genomes between isolates from P0 and P1. We repeatedly screened the two patients and contact patients (i.e., other patients present in the same hospital ward at the time of the first positive sample from P0 or P1; n = 49; 268 tests) with fungal culture and a C. auris-specific quantitative PCR assay to assess transmission patterns. We observed that P1 developed C. auris colonization between 41 and 61 days after potential exposure to P0 contamination, despite three negative screening tests as recommended by our national authorities. This study illustrates that transmission of C. auris between patients can lead to long-term incubation times before the detection of colonization. The recommended screening strategy may not be optimal and should be improved in the light of our findings.

IMPORTANCE While large outbreaks of C. auris in hospital settings have been described, few clear cases of direct transmission have been documented. We here investigated the transmission of C. aurisclade I between two patients with a 41- to 61-day delay between exposure and the development of colonization. This may lead to changes in the recommendations concerning treatment of C. auriscases, as an incubation period of this length is one of the first to be reported.

https://journals.asm.org/doi/10.1128/spectrum.01833-22
 
Back
Top Bottom